I had previously looked at Grail and the Galleri test and understood then (approx 12-18 months ago) that the sensitivity for early stages is poor. Just did a quick google then and came up with the below.
I think IIQ's SubB2M is still in with a very good chance. DYOR of course.
https://www.health.com/condition/cancer/galleri-cancer-blood-test
I had previously looked at Grail and the Galleri test and...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $61.75M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6847 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.0¢ | 9849 | 1 |
View Market Depth
| Last trade - 07.38am 23/08/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |
Day chart unavailable